# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-21-016140
Filing Date
2021-08-09
Accepted
2021-08-09 08:33:32
Documents
21
Period of Report
2021-08-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | aqst-20210809.htm iXBRL | 8-K | 40526
2 | EX-4.1 | supplementalindentureexe.htm | EX-4.1 | 13752
3 | EX-99.1 | ex991_125notereopenerexten.htm | EX-99.1 | 14160
7 |  | image_0a.jpg | GRAPHIC | 62743
8 | GRAPHIC | supplementalindentureexe001.jpg | GRAPHIC | 248622
9 | GRAPHIC | supplementalindentureexe002.jpg | GRAPHIC | 287458
10 | GRAPHIC | supplementalindentureexe003.jpg | GRAPHIC | 316677
11 | GRAPHIC | supplementalindentureexe004.jpg | GRAPHIC | 124139
12 | GRAPHIC | supplementalindentureexe005.jpg | GRAPHIC | 52449
13 | GRAPHIC | supplementalindentureexe006.jpg | GRAPHIC | 46297
| Complete submission text file | 0001628280-21-016140.txt |  | 1792236

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | aqst-20210809.xsd | EX-101.SCH | 2154
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | aqst-20210809_lab.xml | EX-101.LAB | 25268
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | aqst-20210809_pre.xml | EX-101.PRE | 13287
14 | EXTRACTED XBRL INSTANCE DOCUMENT | aqst-20210809_htm.xml | XML | 11735

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 211154770
SIC: 2834 Pharmaceutical Preparations